BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 11974519)

  • 1. Healthcare organizations and the Internet: impact on federal tax exemption.
    Woods L; Osborne M
    J Health Law; 2002; 35(1):1-43. PubMed ID: 11974519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving HMO business practices can threaten tax-exempt status.
    Vecchioni MP
    Healthc Financ Manage; 1997 Sep; 51(9):45-8. PubMed ID: 10170316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IRS and the Internet: new issues for tax-exempt organizations.
    Griffith GM
    Healthc Financ Manage; 2002 Jan; 56(1):46-51. PubMed ID: 11806318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate tax sanctions: an overview.
    Peregrine MW
    Healthc Financ Manage; 1997 Jul; 51(7):56-9. PubMed ID: 10168439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How intermediate sanctions change the dynamics of healthcare transactions.
    Davidson DM; Wester J
    Healthc Financ Manage; 1997 Jul; 51(7):60-1. PubMed ID: 10168440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRS issues new disclosure rules for tax-exempt organizations.
    Luecke RW; Shortill KJ
    Healthc Financ Manage; 1999 Dec; 53(12):52-4. PubMed ID: 11066696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tax sanctions on physician practice acquisitions and employment.
    Hardy CT; Lyden SM; Kasmarcak SJ
    Healthc Financ Manage; 1997 Jul; 51(7):62, 64-6. PubMed ID: 10168441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the new Form 990: implications for hospitals.
    Wright LM; Clancy T; Smith PC
    J Health Care Finance; 2009; 35(4):83-92. PubMed ID: 20515012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tax policy and Health Maintenance Organizations: the case for a section 501(c)(3) tax exemption.
    White AJ
    Am J Law Med; 1980; 6(2):283-313. PubMed ID: 7468601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxpayers' Bill of Rights 2: making sense of the sanctions.
    Calderone BJ
    J Health Hosp Law; 1997 Jun; 30(2):61-74. PubMed ID: 10169577
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposed regulations on taxation of excess benefit transactions.
    Becker S; Grikis L
    Health Care Law Mon; 1998 Oct; ():21-9. PubMed ID: 10346231
    [No Abstract]   [Full Text] [Related]  

  • 12. Is your organization's tax-exempt status at risk?
    Wang T; Wambsganns JR
    Healthc Financ Manage; 1996; Suppl():4-9. PubMed ID: 10162999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. True to form. The IRS' updated reporting rules for tax-exempt organizations could require full disclosure on community benefits, charity care.
    Evans M
    Mod Healthc; 2007 Jun; 37(23):6-7, 16, 1. PubMed ID: 17607903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundraising initiatives and vendor solicitation: avoiding kickback implications.
    Gordon L
    Health Care Law Mon; 2007 Mar; ():3-6. PubMed ID: 17460840
    [No Abstract]   [Full Text] [Related]  

  • 15. Excess benefit transaction regulations: room for improvement.
    Mulholland D
    Health Care Law Mon; 1998 Nov; ():16-9. PubMed ID: 10346228
    [No Abstract]   [Full Text] [Related]  

  • 16. Not exempt from scrutiny. Not-for-profits' actions triggered array of challenges to tax status.
    McLaughlin N
    Mod Healthc; 2004 Jun; 34(23):27. PubMed ID: 15216617
    [No Abstract]   [Full Text] [Related]  

  • 17. Deferred compensation for tax-exempt entities.
    Rich C; Jenkins GE
    Healthc Financ Manage; 1993 Oct; 47(10):54, 56, 58-9. PubMed ID: 10145882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments for tax-exempt healthcare organizations.
    Hyatt TK
    Ann Health Law; 1993; 2():79-93. PubMed ID: 10139970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tax-exempt bonds, Internal Revenue Service releases, Revenue Procedure 97-13.
    Becker S
    Benders Health Care Law Mon; 1997 Apr; ():6-7. PubMed ID: 10168185
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical company sponsored disease management programs: an alternative for tax-exempt MCOs and hospitals.
    Jedrey CM; Chaurette KA; Winn LB
    Manag Care Q; 2002; 10(3):11-5. PubMed ID: 12476660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.